References
- 1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours; vol 2. Lyon, France: IARC Press; 2008:134-136.
- 2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:89-99
- 3. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization. Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon 2001.
- 4. Goasguen JE, Bennett JM, Bain B, Brunning R, Vallespi M-T, Cox C, et al New definitions for blast cells in AML and MDS with validation by virtual microscopy. Leuk Res 2007; 31:Suppl 1:S25.
- 5. Mufti GJ, Bennett JM, Goasguen J. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. H Haematologica.2008;93:1712-1717.
- 6. Jennings CD, Foon KA. Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy. Blood 1997;90:2863-2892
- 7. Lacombe F, Durrieu F, Briais A, Dumain P, Belloc F, Bascans E, et al. Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 1997; 11: 1878-1886
- 8. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
- 9. Leong CF, Kalaichelvi AV, Cheong SK, Hamidah NH, Rahman J, Sivagengei K. Comparison of myeloperoxidase detection by flow cytometry using two different clones of Monoclonal Antibodies. Malays J Pathol 2004;26:111-116.
- 10. Lanza F, Latorraca A, Moretti S, Castagnari B, Ferrari L, Castoldi G. Comparative analysis of different permeabilization methods for flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells. Cytometry 1997;30:134-44.
- 11. Saravaan L, Juneja S. Immunohistochemistry is a more sensitive marker for the detection of acute myeloid leukemia in myeloperoxidase compared with flow cytometry and cytohemistry. Int J Lab Hematology 2010;32:132-136.
- 12. Peffault de Latour R, Legrand O, Moreau D, Perrot JY, Blanc CM, Chaoui D, et al. Comparison of flow cytometry and enzyme cytochemistry for the detection of acute myeloid leukemia myeloperoxidase in: Interests of a new positivity threshold. Br J Haematol 2003;122:211-6.
- 13. Bain JB. Acute leukemia: Integration of Morphological, immunophenotypic and Genatic Information and the WHO classification. in Bain JB. Leukemia diagnosis 4th edition.Wiley Blackwell UK, 2010:114-218.
- 14. Chang H, Salma F, YI QL, Patterson B, Brien B, Minden MDl. Prognostic relevance of immunophenotyping in 379 patiens with acute leukemia. Leuk Res 2004;28(1):43-48.
- 15. Claudio Ortolani. Flow Cytometry of Hematological Malignancies. Wiley Blackwell UK, 2011:168-191.